Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy.
Ries CH, Cannarile MA, Hoves S, Benz J, Wartha K, Runza V, Rey-Giraud F, Pradel LP, Feuerhake F, Klaman I, Jones T, Jucknischke U, Scheiblich S, Kaluza K, Gorr IH, Walz A, Abiraj K, Cassier PA, Sica A, Gomez-Roca C, de Visser KE, Italiano A, Le Tourneau C, Delord JP, Levitsky H, Blay JY, Rüttinger D. Ries CH, et al. Among authors: sica a. Cancer Cell. 2014 Jun 16;25(6):846-59. doi: 10.1016/j.ccr.2014.05.016. Epub 2014 Jun 2. Cancer Cell. 2014. PMID: 24898549 Free article.
Tumor promotion by tumor-associated macrophages.
Porta C, Subhra Kumar B, Larghi P, Rubino L, Mancino A, Sica A. Porta C, et al. Among authors: sica a. Adv Exp Med Biol. 2007;604:67-86. doi: 10.1007/978-0-387-69116-9_5. Adv Exp Med Biol. 2007. PMID: 17695721 Review.
Targeting tumour-associated macrophages.
Sica A, Rubino L, Mancino A, Larghi P, Porta C, Rimoldi M, Solinas G, Locati M, Allavena P, Mantovani A. Sica A, et al. Expert Opin Ther Targets. 2007 Sep;11(9):1219-29. doi: 10.1517/14728222.11.9.1219. Expert Opin Ther Targets. 2007. PMID: 17845147 Review.
RORC1 Regulates Tumor-Promoting "Emergency" Granulo-Monocytopoiesis.
Strauss L, Sangaletti S, Consonni FM, Szebeni G, Morlacchi S, Totaro MG, Porta C, Anselmo A, Tartari S, Doni A, Zitelli F, Tripodo C, Colombo MP, Sica A. Strauss L, et al. Among authors: sica a. Cancer Cell. 2015 Aug 10;28(2):253-69. doi: 10.1016/j.ccell.2015.07.006. Cancer Cell. 2015. PMID: 26267538 Free article.
Inflammation as target in cancer therapy.
Marelli G, Sica A, Vannucci L, Allavena P. Marelli G, et al. Among authors: sica a. Curr Opin Pharmacol. 2017 Aug;35:57-65. doi: 10.1016/j.coph.2017.05.007. Epub 2017 Jun 12. Curr Opin Pharmacol. 2017. PMID: 28618326 Review.
GADD45β Loss Ablates Innate Immunosuppression in Cancer.
Verzella D, Bennett J, Fischietti M, Thotakura AK, Recordati C, Pasqualini F, Capece D, Vecchiotti D, D'Andrea D, Di Francesco B, De Maglie M, Begalli F, Tornatore L, Papa S, Lawrence T, Forbes SJ, Sica A, Alesse E, Zazzeroni F, Franzoso G. Verzella D, et al. Among authors: sica a. Cancer Res. 2018 Mar 1;78(5):1275-1292. doi: 10.1158/0008-5472.CAN-17-1833. Epub 2017 Dec 26. Cancer Res. 2018. PMID: 29279355 Free PMC article.
Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530.
Locatelli SL, Careddu G, Serio S, Consonni FM, Maeda A, Viswanadha S, Vakkalanka S, Castagna L, Santoro A, Allavena P, Sica A, Carlo-Stella C. Locatelli SL, et al. Among authors: sica a. Clin Cancer Res. 2019 Feb 1;25(3):1098-1112. doi: 10.1158/1078-0432.CCR-18-1133. Epub 2018 Oct 23. Clin Cancer Res. 2019. PMID: 30352904
387 results